Timothy Sekosky, DPM
Podiatrist · Phoenix, AZNPI 1487649778
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,975 of the $4,896 with a category attached, or 60.8%. 8 manufacturers reported payments, led by Musculoskeletal Transplant Foundation Inc. at 42.5% of the total. Reporting peaked in 2024 at $1,725 and has fallen 91.7% since, to $144 in 2025.
Across 29 payments — averaging $168.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$2K
- Medline Industries LP$2K
- Vilex LLC$567
- Medshape, Inc.$144
- DJO, LLC$50
- Impactortho, Inc.$30
- plus $28 from 2 others
What the payments were for
- Travel & lodging$1,92239%
- Food & beverage$2,97561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 7 | $2,080 |
| Medline Industries LP | 12 | $1,997 |
| Vilex LLC | 3 | $567 |
| Medshape, Inc. | 1 | $144 |
| DJO, LLC | 3 | $50 |
| Impactortho, Inc. | 1 | $30 |
| Orthofix Medical, Inc. | 1 | $16 |
| Nabriva Therapeutics, PLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALPHALOK$454
How this compares
$4,896 in reported general payments places this provider in the 85th percentile of 151 podiatrist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 33 | $1,181 |
| Ciclopirox | 23 | $827 |
| Etodolac | 11 | $393 |
| Cephalexin | 33 | $315 |
| Doxycycline Hyclate | 19 | $223 |
| Terbinafine Hcl | 13 | $216 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $208 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Phoenix
- Socorro MontesPhoenix$12K
- Richard RandPhoenix$5K
- Gregory LooPhoenix$4K
- Ryan GolubPhoenix$4K
- Ryan PinedoPhoenix$4K
- Suzanne AbrahamPhoenix$4K
- Michael SekoskyPhoenix$3K
- John HarlanPhoenix$3K
- Eric ChenPhoenix$3K
- Seth ClarkPhoenix$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.